HLS- cyclic car peptide: a targeted therapy for pulmonary hypertension
Ended Project Grant Awarded Last action
- Award ID
- R42HL132742
- Recipient
-
Vascular Biosciences UEI ETJLM26WRKP5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,303,971
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- North Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $746,137 | |
| Amendment | $1,255,432 | |
| Original award | $302,402 |
Show all 11
Quick answers
Who received award R42HL132742?
R42HL132742 was awarded to Vascular Biosciences by National Heart Lung and Blood Institute (National Institutes of Health) on August 15, 2017.
How much is award R42HL132742 worth?
$2,303,971 has been obligated on R42HL132742.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award